264 related articles for article (PubMed ID: 28176666)
1. Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress.
Yanaka A
Curr Pharm Des; 2017; 23(27):4066-4075. PubMed ID: 28176666
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane protects small intestinal mucosa from aspirin/NSAID-induced injury by enhancing host defense systems against oxidative stress and by inhibiting mucosal invasion of anaerobic enterobacteria.
Yanaka A; Sato J; Ohmori S
Curr Pharm Des; 2013; 19(1):157-62. PubMed ID: 22950492
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane enhances protection and repair of gastric mucosa against oxidative stress in vitro, and demonstrates anti-inflammatory effects on Helicobacter pylori-infected gastric mucosae in mice and human subjects.
Yanaka A
Curr Pharm Des; 2011; 17(16):1532-40. PubMed ID: 21548875
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
Slomiany BL; Piotrowski J; Slomiany A
J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
[TBL] [Abstract][Full Text] [Related]
5. The effect of non-steroidal anti-inflammatory drugs and Helicobacter pylori infection on the gastric mucosa in children with upper gastrointestinal bleeding.
Boukthir S; Mazigh SM; Kalach N; Bouyahya O; Sammoud A
Pediatr Surg Int; 2010 Feb; 26(2):227-30. PubMed ID: 19823852
[TBL] [Abstract][Full Text] [Related]
6. Suppression of expression of endoplasmic reticulum chaperones by Helicobacter pylori and its role in exacerbation of non-steroidal anti-inflammatory drug-induced gastric lesions.
Namba T; Hoshino T; Suemasu S; Takarada-Iemata M; Hori O; Nakagata N; Yanaka A; Mizushima T
J Biol Chem; 2010 Nov; 285(48):37302-13. PubMed ID: 20861013
[TBL] [Abstract][Full Text] [Related]
7. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans.
Yanaka A; Fahey JW; Fukumoto A; Nakayama M; Inoue S; Zhang S; Tauchi M; Suzuki H; Hyodo I; Yamamoto M
Cancer Prev Res (Phila); 2009 Apr; 2(4):353-60. PubMed ID: 19349290
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
9. Gastric mucosal blood flow changes in Helicobacter pylori infection and NSAID-induced gastric injury.
Elizalde JI; Mendez A; Gomez J; del Rivero M; Gironella M; Closa D; Quintero E; Pique JM
Helicobacter; 2003 Apr; 8(2):124-31. PubMed ID: 12662380
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils.
Bhang CS; Lee HS; Kim SS; Song HJ; Sung YJ; Kim JI; Chung IS; Sun HS; Park DH; Lee YS
Helicobacter; 2002 Feb; 7(1):14-21. PubMed ID: 11886470
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Helicobacter pylori and nonsteroidal anti-inflammatory drug-induced gastric epithelial injury.
Igarashi M; Takagi A; Jiang X; Hasumi K; Watanabe S; Deguchi R; Miwa T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():235-9. PubMed ID: 11966547
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J; Saito Y; Honda A; Matsuzaki Y
World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
[TBL] [Abstract][Full Text] [Related]
13. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation.
Tanigawa T; Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Oshitani N; Tarnawski AS; Arakawa T
J Gastroenterol; 2009; 44 Suppl 19():8-17. PubMed ID: 19148787
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Protects against Helicobacter pylori-Associated Gastritis by Combating Oxidative Stress.
Zhang X; Jiang A; Qi B; Ma Z; Xiong Y; Dou J; Wang J
Int J Mol Sci; 2015 Nov; 16(11):27757-69. PubMed ID: 26610474
[TBL] [Abstract][Full Text] [Related]
17. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
18. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs.
McCarthy DM
Scand J Gastroenterol Suppl; 1991; 187():91-7. PubMed ID: 1775931
[TBL] [Abstract][Full Text] [Related]
20. Relationship between nonsteroidal anti-inflammatory drug use, Helicobacter pylori, and gastroduodenal mucosal injury.
Wilcox CM
Gastroenterology; 1997 Dec; 113(6 Suppl):S85-9. PubMed ID: 9394766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
